Fungispecificity of fluconazole against Candida albicans.
Candida albicans is an opportunistic pathogen of human mucosal surfaces. Colonization of oral and vaginal mucosa by this yeast is antagonized by the resident normal bacterial population. However, antibacterial therapy can alter the normal flora to allow fungal cells to attach, grow and invade host tissues. We studied the antimicrobic activity of fluconazole against clinical isolates of oral and vaginal bacteria and Candida albicans in vitro and in vivo by scanning and transmission electron microscopy; we also compared the bactericidal activity of fluconazole with clotrimazole in vitro by microbiologic assay. Fluconazole lysed fungi but did not change the ultrastructure of bacteria. Clotrimazole, but not fluconazole, was bactericidal against lactobacillus and streptococcus, the principal species of the oral and vaginal cavities. We conclude that Candida albicans, but not oral and vaginal bacteria, is susceptible to fluconazole. These observations help explain the antimycotic specificity of fluconazole and its efficacy against candidiasis in humans.
Liss
R H
RH
Department of Surgery, Children's Hospital Medical Center, Boston, MA 02115.
Letourneau
R J
RJ
D002176:Candida albicans / Q000187:drug effects* / Q000648:ultrastructure; D003022:Clotrimazole / Q000494:pharmacology; D005260:Female; D015725:Fluconazole / Q000494:pharmacology*; D006801:Humans; D007778:Lactobacillus / Q000187:drug effects; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning; D009061:Mouth Mucosa / Q000382:microbiology; D009092:Mucous Membrane / Q000382:microbiology; D013045:Species Specificity; D013291:Streptococcus / Q000187:drug effects; D014621:Vagina / Q000382:microbiology
D015725:Fluconazole; D003022:Clotrimazole